European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The H4-Index of European Heart Journal-Quality of Care and Clinical Outcomes is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Ambulance drive-thru troponin, ready to go?94
Letter to the editor in response to Kobo et al. 202275
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor72
Evolving perspectives in personalized cardiovascular care65
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease53
Association of lipoprotein(a) level and major adverse cardiovascular events in adult cancer survivors with atherosclerotic disease49
Secundum atrial septal defect closure in adults in the UK40
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events36
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease34
Beyond biomarkers: the relevance of supporting evidence in the diagnosis of periprocedural myocardial infarction34
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis33
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm33
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations29
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings29
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations29
Beyond the SMuRF-less paradox: disaggregation may restore clinical meaning27
Intracoronary imaging for percutaneous coronary intervention: worth the cost?26
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–2026
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes25
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings24
Lower STEMI mortality at high volume tertiary centre: Insights from a compact multi-centre region24
Correction to: Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry23
Mitral valve prolapse: incidence and prognosis related to serum levels of sex hormone-binding globulin22
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study22
Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalities22
0.81520104408264